MENU
ACAD
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
ACADIA Pharmaceuticals (ACAD) Ownership - Who owns ACADIA Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
12830 El Camino Real
Phone
+1 858 558-2871
Employees
598
Web
https://www.acadia.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.6B
P/E Ratio
81.00
Total Cash
500.94M
Projected Growth
N/A
Total Debt
57.66M
Revenue
890.53M
Risk (Beta)
0.76
Dividend Yield
N/A
Total Cash/Share
3.02
Total Debt/Equity
N/A
Revenue/Share
5.38 USD as % of share price
Fundamentals
ACAD
Capitalization
2.6B
P/E Ratio
81.00
Risk (Beta)
0.76
Dividend Yield
N/A
Total Cash
501M
Total Cash/Share
3.02
Total Debt
57.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.38%
Revenue
891M
ROE
N/A
Book Value
517M
P/B Ratio
4.94
Cash Flow
N/A
Earnings
0.19
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
16K
Current Ratio
2.16
Current Revenue Per Employee
350671.00
Dividends Per Share - Security
N/A
EBITDA
34.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
92.47
Revenue To Assets
3.93
Shares Held By Institutions
5.66B
Shares Outstanding - Current
166M
Total Liabilities
397M
Total Volume MTD
N/A
Value
-1
Gain YTD
-53.625
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceuticals drugs for treatment of central nervous system disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
12830 El Camino Real
Phone
+1 858 558-2871
Employees
598
Web
https://www.acadia.com